pageInfo({
    time : "1261151430180"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "INN0230915220080602"
	        , headline : "Better genetic tests fine tune cancer therapy"
	        , keywords : "[Healthcare, Pharmaceuticals - generic and speciality, Pharmaceuticals - diversified, Western Europe, Europe, Online Report text item, Germany, Chemicals, Biotechnology, Pharmaceuticals (sub-industry), Pharmaceuticals and biotechnology, United States of America, Central and Eastern Europe, Canada]"
	        , tickers : "[AMGN.O, IMCL.O, MRCG.DE, mx;AMGN, mx;BMY, mx;GSKN, us;AMGN, us;BMY, us;DNA, us;GLAX, us;GSK, us;IMCL, us;MERP, GSK.L, gb;GSK, BMY.N, ch;AMGN, ch;MRK, de;BRM, de;BRMF, de;BRMS, de;BRMX, de;GS7, de;MRK, de;MRKX, DNA.N, gb;AP47, us;MRK]"
	    }
	    , channel : {
	        id : "6"
	        , name : "newsOne"
	        , title : "Top News"
	    }})